STEMI, primary percutaneous coronary intervention and recovering of life expectancy: insights from the SurviSTEMI study

Pascual, Isaac; Avanzas, Pablo; Almendárez, Marcel; Lorca, Rebeca; Vigil-Escalera, María; Arboine, Luis; Alperi, Alberto; Adeba, Antonio; Díaz, Rocío; Silva, Jacobo; Morı́s, César; Hernández-Vaquero, Daniel

doi:10.1016/j.rec.2020.08.008

Cited by 5 publications

(6 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Radial approach (RA) has been widely adopted in percutaneous coronary interventions (PCIs) [1][2][3][4][5][6]. A growing body of evidence demonstrated the advantage of the RA over the femoral approach (FA) in PCI for ST-segment elevation myocardial infarction (STEMI) [1][2][3][4][5][6][7][8].…”

Section: Introductionmentioning

confidence: 99%

Radial approach reduces mortality in ST-segment elevation myocardial infarction with cardiogenic shock

Tokarek¹,

Dziewierz²,

Plens³

et al. 2021

Polish Archives of Internal Medicine

View full text Add to dashboard Cite

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited, distributed under the same license, and used for noncommercial purposes only.

show abstract

Section: Introductionmentioning

confidence: 99%

Radial approach reduces mortality in ST-segment elevation myocardial infarction with cardiogenic shock

Tokarek¹,

Dziewierz²,

Plens³

et al. 2021

Polish Archives of Internal Medicine

View full text Add to dashboard Cite

show abstract

“…The preferable treatment choice in most of the patients with STEMI has greatly emerged to be the PCI with the implantation of stent. [12][13][14] Drug-eluting stents (DES), in comparison with Bare-Metal Stents (BMS), are known to be associated with reduced stent thrombosis and improved revascularization of the target lesion in the patients with stable coronary artery disease and acute coronary syndromes also including STEMI. 4,15,16 However, there is persistence of safety concerns related to greater risk of late and very late stent thrombosis specially with drug-eluting stents 40-42 and in off-label use, for example in STEMI patients.…”

Section: Discussionmentioning

confidence: 99%

Frequency of Subacute Stent Thrombosis (SAT) in Patients Presenting with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (PCI)

Ali

Abbasi²,

Zafar³

et al. 2022

PAFMJ

View full text Add to dashboard Cite

Objective: To assess the rate of occurrence of sub-acute Stent Thrombosis (SAT) after primary PCI in the patients presented with the acute coronary syndrome. Study Design: Retrospective cross-sectional study. Place and Duration of Study: At Tertiary Cardiac Care Center of Lahore Pakistan, from Jul 2019 to Jun 2021. Methodology: The retrospective demographical and angiographic data of the admitted patients who underwent PCI for ACS,was gathered from the Hospital Registry of a tertiary cardiac care center of Lahore. The sampling technique was nonprobability consecutive sampling, and all the data was analyzed using SPSS 20.0 and continuous data was presented as Mean±SD and frequencies & percentages for categorical variables. Chi square test (CI=95%, α=5%) was used to find the association of SAT with predisposing factors. p-value < 0.05 was taken as statistically significant. Results: Out of (n=551) patient underwent PPCI, the stent thrombosis was observed to occur in 29(5.2 %), among which 4.9 % were subacute stent thrombosis. The predisposing factors of sub-acute stent thrombosis were Diabetes Mellitus, ACS, smaller vessel size, presence of bifurcation lesion, under sizing of the stent and edge dissection and were in significant association with SAT (p < 0.05). Conclusion: Our study reveals that subacute stent thrombosis is an event with a comparatively higher frequency in patients who go through primary PCI for acute coronary syndrome, demonstrating a frequency of 4.9% and a mortality rate of 74% within 30 days of the procedure.

show abstract

“…The statistical process comparing the survival rate of patients experiencing premature STEMI with that of the general population of the same sex, age, and region was calculated as reported elsewhere [ 21 , 22 ].…”

Section: Methodsmentioning

confidence: 99%

Premature STEMI in Men and Women: Current Clinical Features and Improvements in Management and Prognosis

Lorca

Pascual

Aparicio

et al. 2021

JCM

Self Cite

View full text Add to dashboard Cite

Background: Coronary artery disease (CAD) is the most frequent cause of ST-segment elevation myocardial infarction (STEMI). Etiopathogenic and prognostic characteristics in young patients may differ from older patients and young women may present worse outcomes than men. We aimed to evaluate the clinical characteristics and prognosis of men and women with premature STEMI. Methods: A total 1404 consecutive patients were referred to our institution for emergency cardiac catheterization due to STEMI suspicion (1 January 2014–31 December 2018). Patients with confirmed premature (<55 years old in men and <60 in women) STEMI (366 patients, 83% men and 17% women) were included (359 atherothrombotic and 7 spontaneous coronary artery dissection (SCAD)). Results: Premature STEMI patients had a high prevalence of classical cardiovascular risk factors. Mean follow-up was 4.1 years (±1.75 SD). Mortality rates, re-hospitalization, and hospital stay showed no significant differences between sexes. More than 10% of women with premature STEMI suffered SCAD. There were no significant differences between sexes, neither among cholesterol levels nor in hypolipemiant therapy. The global survival rates were similar to that expected in the general population of the same sex and age in our region with a significantly higher excess of mortality at 6 years among men compared with the general population. Conclusion: Our results showed a high incidence of cardiovascular risk factors, a high prevalence of SCAD among young women, and a generally good prognosis after standardized treatment. During follow-up, 23% suffered a major cardiovascular event (MACE), without significant differences between sexes and observed survival at 1, 3, and 6 years of follow-up was 96.57% (95% CI 94.04–98.04), 95.64% (95% CI 92.87–97.35), and 94.5% (95% CI 91.12–97.66). An extra effort to prevent/delay STEMI should be invested focusing on smoking avoidance and optimal hypolipemiant treatment both in primary and secondary prevention.

show abstract

STEMI, primary percutaneous coronary intervention and recovering of life expectancy: insights from the SurviSTEMI study

Cited by 5 publications

References 30 publications

Radial approach reduces mortality in ST-segment elevation myocardial infarction with cardiogenic shock

Radial approach reduces mortality in ST-segment elevation myocardial infarction with cardiogenic shock

Frequency of Subacute Stent Thrombosis (SAT) in Patients Presenting with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (PCI)

Premature STEMI in Men and Women: Current Clinical Features and Improvements in Management and Prognosis

Contact Info

Product

Resources

About